INTRODUCTION: Delayed graft function (DGF) is more common in recipients of kidney transplants from donation after cardiac death (DCD) donors compared to donation after brain death (DBD) donors. METHODS: Single-center retrospective study to evaluate the impact of DGF on controlled (Maastricht category III) DCD donor kidney transplant outcomes. RESULTS: From 10/01 to 6/08, 578 adult deceased donor kidney transplants were performed including 70 (12%) from DCD and 508 (88%) from DBD donors. Mean follow-up was 36 months. DCD donor kidney transplants had significantly greater rates of DGF (57% DCD vs. 21% DBD, p < 0.0001)) and acute rejection (29% DCD vs. 16% DBD, p = 0.018) compared to DBD donor kidney transplants, but patient and graft survival rates were similar. DBD donor kidney transplants with DGF (n = 109) had significantly greater rates of death-censored graft loss (12.5% DCD vs. 31% DBD), primary non-function (0 DCD vs. 10% DBD) and higher 2 year mean serum creatinine levels (1.4 DCD vs. 2.7 mg/dL DBD) compared to DCD donor kidney transplants with DGF (n = 40, all p < 0.04). On univariate analysis, the presence of acute rejection and older donor age were the only significant risk factors for death-censored graft loss in DCD donor kidney transplants, whereas DGF was not a risk factor. CONCLUSION: Despite higher rates of DGF and acute rejection in DCD donor kidney transplants, subsequent outcomes in DCD donor kidney transplants with DGF are better than in DBD donor kidney transplants experiencing DGF, and similar to outcomes in DCD donor kidney transplants without DGF.
INTRODUCTION: Delayed graft function (DGF) is more common in recipients of kidney transplants from donation after cardiac death (DCD) donors compared to donation after brain death (DBD) donors. METHODS: Single-center retrospective study to evaluate the impact of DGF on controlled (Maastricht category III) DCDdonor kidney transplant outcomes. RESULTS: From 10/01 to 6/08, 578 adult deceased donor kidney transplants were performed including 70 (12%) from DCD and 508 (88%) from DBD donors. Mean follow-up was 36 months. DCDdonor kidney transplants had significantly greater rates of DGF (57% DCD vs. 21% DBD, p < 0.0001)) and acute rejection (29% DCD vs. 16% DBD, p = 0.018) compared to DBDdonor kidney transplants, but patient and graft survival rates were similar. DBDdonor kidney transplants with DGF (n = 109) had significantly greater rates of death-censored graft loss (12.5% DCD vs. 31% DBD), primary non-function (0 DCD vs. 10% DBD) and higher 2 year mean serum creatinine levels (1.4 DCD vs. 2.7 mg/dL DBD) compared to DCDdonor kidney transplants with DGF (n = 40, all p < 0.04). On univariate analysis, the presence of acute rejection and older donor age were the only significant risk factors for death-censored graft loss in DCDdonor kidney transplants, whereas DGF was not a risk factor. CONCLUSION: Despite higher rates of DGF and acute rejection in DCDdonor kidney transplants, subsequent outcomes in DCDdonor kidney transplants with DGF are better than in DBDdonor kidney transplants experiencing DGF, and similar to outcomes in DCDdonor kidney transplants without DGF.
Authors: Kyle J Van Arendonk; Nathan T James; Jayme E Locke; Robert A Montgomery; Paul M Colombani; Dorry L Segev Journal: Clin J Am Soc Nephrol Date: 2011-09-22 Impact factor: 8.237
Authors: I E Hall; R S Bhangoo; P P Reese; M D Doshi; F L Weng; K Hong; H Lin; G Han; R D Hasz; M J Goldstein; B Schröppel; C R Parikh Journal: Am J Transplant Date: 2014-02-24 Impact factor: 8.086
Authors: Sanjay Kulkarni; Guo Wei; Wei Jiang; Licia A Lopez; Chirag R Parikh; Isaac E Hall Journal: Am J Kidney Dis Date: 2019-12-05 Impact factor: 8.860
Authors: I E Hall; B Schröppel; M D Doshi; J Ficek; F L Weng; R D Hasz; H Thiessen-Philbrook; P P Reese; C R Parikh Journal: Am J Transplant Date: 2015-03-11 Impact factor: 8.086
Authors: Isaac E Hall; Peter P Reese; Francis L Weng; Bernd Schröppel; Mona D Doshi; Rick D Hasz; William Reitsma; Michael J Goldstein; Kwangik Hong; Chirag R Parikh Journal: Clin J Am Soc Nephrol Date: 2014-02-20 Impact factor: 8.237
Authors: Isaac E Hall; Peter P Reese; Mona D Doshi; Francis L Weng; Bernd Schröppel; William S Asch; Joseph Ficek; Heather Thiessen-Philbrook; Chirag R Parikh Journal: Transplantation Date: 2017-08 Impact factor: 4.939
Authors: Xuanchuan Wang; Min Xu; Jianluo Jia; Zhengyan Zhang; Joseph P Gaut; Gundumi A Upadhya; Pamela T Manning; Yiing Lin; William C Chapman Journal: Am J Transplant Date: 2017-11-01 Impact factor: 8.086